Monthly Archives: January 2011

Weekly Roundup – 1/28/11

Posted on January 28, 2011 by Mark Senak

Well, we had a winter of no snow.  Then on Wednesday they said it would start at 4 o’clock. At precisely 4 PM I looked out my office window and darn if it didn’t begin to snow – the heavy … Continue reading →

Posted in Weekly Roundup | 1 Comment

Growing Role of Social Media Among Policymakers

Posted on January 26, 2011 by Mark Senak

It is perhaps hard to believe that only four years ago, the following sentence would have made no sense to anyone at all.  “I follow you on Twitter.”  Many of us, though not all of us, would have been bewildered … Continue reading →

Posted in Current Affairs, New and Social Media, Politics | 4 Comments

The FDA Guidance System Needs a Fix

Posted on January 25, 2011 by Mark Senak

Back in March 2010, in a posting on the FDA’s Transparency Blog – the FDA asked the question “How Can FDA Improve the Guidance Process.”  The responses in the form of comments to the posting are primarily made up of … Continue reading →

Posted in FDA Policy | 1 Comment

Weekly Roundup 1/21/11

Posted on January 21, 2011 by Mark Senak

It has been a nearly snow-less winter here in Washington, in contrast of course to last winter when I was housebound for nearly a week.  Let me just say, I find neither of these extremes particularly desireable…. More importantly, here … Continue reading →

Posted in Uncategorized | Comments Off on Weekly Roundup 1/21/11

DDMAC Warning and NOV Letters – LookBack for 2010

Posted on January 20, 2011 by Mark Senak

FDA’s Division for Drug Marketing, Advertising and Communications (DDMAC) is responsible for regulating the communications by medical product manufacturers with the public about their products.  During 2010, the agency issued 52 letters, which is more than during any year since … Continue reading →

Posted in Warning Letters | 1 Comment